x

Search for a diagnostic test

* (*) mandatory field

23 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation ;

GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation Molecular diagnosis of multiple endocrine neoplasia type 1 (MEN1 gene)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technical procedure(s) : Sanger sequencing

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Molecular diagnosis of intestinal carcinoid tumors (SDHD gene)
Pränatalmedizin München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technical procedure(s) : Sanger sequencing

More information
FRANCE

NORD-PAS-DE-CALAIS
LILLE

Accreditation Diagnosis of endocrine diseases (Panel)
CHRU de Lille - Centre de Biologie Pathologie Génétique
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technical procedure(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
GERMANY

Bayern
WÜRZBURG

Accreditation Molecular diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universität Würzburg - Biozentrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technical procedure(s) : NGS sequencing (except WES)

More information
GERMANY

Baden-Württemberg
ULM

Accreditation Molecular diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universitätsklinikum Ulm
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technical procedure(s) : NGS sequencing (except WES)

More information
FRANCE

MIDI-PYRENEES
TOULOUSE

Accreditation Diagnosis of endocrine tumors (Panel)
CHU de Toulouse - Hôpital Purpan
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : NGS sequencing (except WES)

More information
SPAIN

País Vasco
SAN SEBASTIÁN

Molecular diagnosis of endocrine tumor (TMEM127, SDHD, SHCD, CDC73, SDHB, SDHAF2, VHL, MEN1, AIP genes / array-CGH)
Policlínica Gipuzkoa
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Deletion / Duplication analysis
Technical procedure(s) : Array based techniques

More information
SPAIN

País Vasco
BARAKALDO

Molecular diagnosis of Zollinger-Ellison syndrome (MEN1 gene)
Hospital Universitario Cruces - Osakidetza
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
FRANCE

ILE-DE-FRANCE
PARIS

Diagnosis of endocrine diseases (Panel)
CHU Paris Centre - Hôpital Cochin
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : NGS sequencing (except WES)

More information
FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Diagnosis of endocrine tumors (Panel)
CHU de Marseille - Hôpital de la Conception
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : NGS sequencing (except WES)

More information
FRANCE

PAYS DE LA LOIRE
ANGERS

Diagnosis of tumors (Panel)
CHU d'Angers
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technical procedure(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Sachsen
DRESDEN

Molecular diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technical procedure(s) : NGS sequencing (except WES)

More information
FRANCE

HAUTE-NORMANDIE
ROUEN

Histological and immunohistological of neuroendocrine tumor of the pancreas and digestive tube
CHU de Rouen - Hôpital Charles Nicolle
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Biochemical genetics, Pathology
Objective(s) : Protein expression
Technical procedure(s) : Immunohistochemistry

More information
GERMANY

Thüringen
BAD BERKA

Nuclear medicine diagnosis of neuroendocrine tumors (gallium-68 somatostatin Receptor-PET/CT)
Zentralklinik Bad Berka GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Imaging

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening of gastrointestinal cancer syndromes (C-KIT 4q12)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for gastrointestinal cancer (C-KIT 4q12)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for gastrointestinal cancer (PDFGRA 4q12)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for gastrointestinal cancer (PDFGRA 4q12)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for gastrointestinal cancer (CDH1 16q22.1)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for gastrointestinal cancer (CDH1 16q22.1)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for gastrointestinal cancer (VHL 3p25.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for gastrointestinal cancer (VHL 3p25.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
FRANCE

CENTRE
TOURS

Diagnosis of cutaneous neuroendocrine carcinoma (detection of antibodies against T antigens)
Faculté de pharmacie de Tours
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Virology

More information